REVISIÓN
Inhibidores de PCSK9: ratificación del papel del colesterol LDL en prevención cardiovascular. ¿Hacia la convergencia en las guías de prevención europeas y norteamericanas?
PCSK9 inhibitors: Ratification of the role of LDL cholesterol in cardiovascular prevention. Towards a convergence of European and North American prevention guidelines?
Leído
227
Vecesse ha leído el artículo
56
Total PDF
171
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 2 | 0 | 2 |
| 2025 2 | 1 | 2 | 3 |
| 2023 5 | 1 | 3 | 4 |
| 2023 3 | 6 | 6 | 12 |
| 2021 5 | 3 | 2 | 5 |
| 2021 3 | 3 | 2 | 5 |
| 2021 2 | 2 | 2 | 4 |
| 2020 12 | 2 | 4 | 6 |
| 2020 11 | 1 | 2 | 3 |
| 2020 10 | 2 | 2 | 4 |
| 2020 9 | 3 | 4 | 7 |
| 2020 8 | 30 | 16 | 46 |
| 2020 6 | 0 | 2 | 2 |
| 2019 10 | 1 | 3 | 4 |
| 2019 8 | 2 | 4 | 6 |
| 2019 7 | 112 | 2 | 114 |
Mostrar todo
